Back

Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis: a sub study of the IIISAS randomised trial

12 May 2024 (16:51 - 17:00)
Organised by: Logo
Congress Presentation Part of: Improving prognosis in aortic valve disease Treatment HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor August Magnus Stensroed Floe

Oslo University Hospital Rikshospitalet, Oslo (Norway)

6 More presentations in this session

Presentation thumbnail
Myocardial work predicts left ventricular dysfunction following transcatheter aortic valve replacement in patients with aortic valve stenosis
Doctor M. Vanderheyden (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Myocardial work assessment for immediate changes in left ventricular function and survival analysis after transcatheter aortic valve replacement
Miss A. Moya (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of non-severe paravalvular leak after transcatheter aortic valve implantation.
Doctor B. Lacerda Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Predictors of survival in decompensated HfpEF with moderate aortic stenosis
Doctor M. Shumkova (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
Histological tissue characterization of myocardial remodelling in endomyocardial biopsies from patients with severe aortic valvular disease
Miss L. Tapia (Pamplona, Navarra, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Improving prognosis in aortic valve disease
Video

The Event

Event poster

Heart Failure 2024

12 May 2024 16:51 CET
You may be interested in
thumbnail
Congress Presentation
Iron therapy
thumbnail
Congress Presentation
Treatment of iron deficiency in heart failure in 2023
thumbnail
Congress Presentation
New IV iron trials